{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.157G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "157"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T mutation in a-synuclein gene"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Familial Parkinson's Disease",
        "MONDO": "MONDO:0008199"
    },
    "Experiment Method": [
        {
            "Assay Method": "Immunohistochemical Analysis",
            "Material used": {
                "Material Source": "Postmortem Tissue",
                "Material Name": "Brain Tissue from Contursi Kindred Patient IX-51",
                "Description": "Postmortem brain tissue from a patient in the Contursi kindred carrying the A53T a-syn gene mutation was used for immunohistochemical analysis."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.157G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Extensive spheroids and Lewy neurites were detected in multiple brain regions, indicating widespread a-syn pathology associated with the A53T mutation."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "No",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Absence of spheroids and Lewy neurites in brain regions.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Presence of spheroids and Lewy neurites in brain regions.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Biochemical Analysis (Sequential Extraction and Western Blotting)",
            "Material used": {
                "Material Source": "Postmortem Tissue",
                "Material Name": "Brain Tissue from Contursi Kindred Patient IX-51",
                "Description": "Frozen brain tissue from multiple regions of a patient in the Contursi kindred carrying the A53T a-syn gene mutation was used for biochemical analysis."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.157G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Significant accumulation of insoluble a-synuclein requiring SDS or formic acid for extraction was observed in multiple brain regions, indicating altered protein solubility due to the A53T mutation."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "No",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Control brain tissue from a pathologically normal brain was used for comparison."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "a-Synuclein fully extractable in high salt buffer or with mild detergent.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "a-Synuclein requiring SDS or formic acid for extraction.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ultrastructural Analysis (Immuno-Electron Microscopy)",
            "Material used": {
                "Material Source": "Postmortem Tissue",
                "Material Name": "Brain Tissue from Contursi Kindred Patient IX-51",
                "Description": "Brain sections from a patient in the Contursi kindred carrying the A53T a-syn gene mutation were used for ultrastructural analysis."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.157G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Filamentous ultrastructure of a-synuclein inclusions was observed, confirming fibrillar pathology associated with the A53T mutation."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "No",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Absence of filamentous structures in brain tissue sections.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Presence of filamentous structures in brain tissue sections.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In Vitro Fibril Formation Assay",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Recombinant WT and A53T a-Synuclein, Tau T40",
                "Description": "Recombinant wild-type and A53T mutant a-synuclein, along with tau T40 protein, were used for in vitro fibrillization studies."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.157G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A53T mutation accelerated a-synuclein fibril formation and enhanced tau fibrillization compared to wild-type a-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Four samples (n=4) were analyzed for each condition."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type a-synuclein was used as a control for comparison with A53T mutant."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Quantitative analysis using ImageQuant software for sedimentation analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Fibrillization rate comparable to wild-type a-synuclein.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Accelerated fibrillization rate compared to wild-type a-synuclein.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}